Muutke küpsiste eelistusi

Applied Methods of Cost-Benefit Analysis in Health Care [Pehme köide]

Edited by (Health Economics Research Centre, Department of Public Health, University of Oxford, UK), Edited by (Professor of Marketing and Executiv), Edited by (The University of Sydney, Australia), Edited by (Senior Lecturer in Health Economics, University of Birmingham, UK)
  • Formaat: Paperback / softback, 288 pages, kõrgus x laius x paksus: 234x156x22 mm, kaal: 452 g, 17 black and white line drawings
  • Sari: Handbooks in Health Economic Evaluation 4
  • Ilmumisaeg: 24-Jun-2010
  • Kirjastus: Oxford University Press
  • ISBN-10: 0199237123
  • ISBN-13: 9780199237128
  • Formaat: Paperback / softback, 288 pages, kõrgus x laius x paksus: 234x156x22 mm, kaal: 452 g, 17 black and white line drawings
  • Sari: Handbooks in Health Economic Evaluation 4
  • Ilmumisaeg: 24-Jun-2010
  • Kirjastus: Oxford University Press
  • ISBN-10: 0199237123
  • ISBN-13: 9780199237128
This book provides the reader with a comprehensive set of instructions and examples of how to perform a cost-benefit analysis (CBA) of a health intervention. Developed out of a course run by Jordan Louviere at the University of Technology, Sydney, entitled An Introduction to Stated Preference Discrete Choice Modelling it has a particular focus on the use of stated preference survey methods to identify consumer preference data, as well as the use of recent developments in cost-effectiveness analysis within a CBA framework. In doing so, the most up to date methodologies for CBA are compiled in a comprehensive manner with the aim of advancing the methodology of CBA in healthcare.

ABOUT THE SERIES
Series editors Alastair Gray and Andrew Briggs

Economic evaluation of health intervention is a growing specialist field, and this series of practical handbooks tackles, in depth, topics superficially addressed in more general economics books. Each volume includes illustrative material, case histories and worked examples to encourage the reader to apply the methods discussed, with supporting material provided online. The series is aimed at health economists in academia, the pharmaceutical industry and the health sector, those on advanced health economics courses, and health researchers in associated fields.
Contributors xiii
1 Introduction
1(18)
Emma McIntosh
2 Methods for evaluating health and health care: Underlying theory and implications for practical application
19(20)
Philip M. Clarke
3 Shadow pricing in health care cost-benefit analyses
39(16)
Emma McIntosh
4 Costing methodology for applied cost-benefit analysis in health care
55(24)
Emma McIntosh
5 Valuation and cost-benefit analysis in health and environmental economics
79(18)
F. Reed Johnson
W.L. (Vic) Adamowicz
6 Benefit assessment for cost-benefit analysis studies in health care using contingent valuation methods
97(22)
Emma J. Frew
7 Benefit assessment for cost-benefit analysis studies in health care: A guide to carrying out a stated preference willingness to pay survey in health care
119(20)
Emma J. Frew
8 Applied cost-benefit analysis in health care: An empirical application in spinal surgery
139(22)
Emma McIntosh
Alastair Gray
Mathias Haefeli
Achim Elfering
Atul Sukthankar
Norbert Boos
9 Using revealed preference methods to value health care: The travel cost approach
161(24)
Philip M. Clarke
10 Experimental design and the estimation of willingness to pay in choice experiments for health policy evaluation
185(26)
Richard T. Carson
Jordan J. Louviere
11 Benefit assessment for cost-benefit analysis studies in health care using discrete choice experiments: Estimating welfare in a health care setting
211(20)
Jordan J. Louviere
Denzil G. Fiebig
12 A practical guide to reporting and presenting stated preference discrete choice experiment results in cost-benefit analysis studies in health care
231(28)
Emma McIntosh
13 The relevance of cost-benefit analysis in health care: Concluding comments
259(4)
Emma McIntosh
W.L. (Vic) Adamowicz
F. Reed Johnson
Index 263
Dr Emma McIntosh joined the Health Economics Research Centre in August 2000. Emma has an MSc in Health Economics and a PhD in Economics. Prior to joining HERC Emma worked in the Health Economics Research Unit at the University of Aberdeen developing and applying stated preference discrete choice methods in health economics as well as carrying out economic evaluations alongside a number of trials in the areas of laparoscopic hernia repair and guidelines for urology. At HERC, Emma is working on a number of trials in Parkinson's Disease, stroke and home visiting as well as continuing her interest in developing the methodology of discrete choice experiments.

Dr Emma Frew moved to Birmingham in March 2002, having previously worked at the University of Nottingham, where she obtained her PhD in health economics. Her research interests are broad but generally centre around methodological issues of outcome valuation, especially contingent valuation, and the use of economic tools within childhood populations. Emma has worked on various projects exploring the use of contingent valuation and has published widely in this area. As well as her work within contingent valuation, Emma is responsible for the health economics element of the West Midlands Research Design Service, leads the academic unit research theme in Cancer and has an interest in the development and changing trends of health economics teaching.

Jordan Louviere was previously on the faculties of Sydney University, University of Utah, University of Alberta, University of Iowa, University of Wyoming and Florida State University. His current research projects include integration of structural equation and choice models, choice models for single persons, integration of basic science with choice models, the behavior of the error variance in latent dependent variable models, measurement models based on best-worst choices and theory and methods for valuing the equity of brands. He works with Australia, US and other firms on choice modeling applications. He is on the editorial boards of the Journal of Choice Modeling, and the International Journal of Research in Marketing. He is an OZ Reader for the Australian Research Council, and has received numerous research grants from NSF, SSHRC, ARC and other funding sources.